Lewes, DE -- (SBWIRE) -- 06/26/2015 -- Report forecast the global cancer vaccines market to grow at a CAGR of 27.24% over the period 2014-2019.

Cancer vaccines are biological preparations that stimulate or strengthen a person's immune system against cancer. Cancer vaccines are usually administered intravenously. They can be used in both adults and children. The vaccines can be broadly classified into two: prophylactic and therapeutic vaccines. Prophylactic vaccines are used for the prevention of cancer, whereas therapeutic vaccines are used for treatment of cancer.

This report covers the present scenario and the growth prospects of the global cancer vaccines market for the period 2015-2019. To calculate the market size, the report considers revenue generated from the sales of various therapeutic and prophylactic cancer vaccines.

This report covers the present scenario and the growth prospects of the global cancer vaccines market for the period 2015-2019 in the following three regions:
- Americas: The principal countries focused upon in this region are the US, Canada, Mexico, and Brazil
- EMEA: The principal countries focused upon in this region are the UK; Germany; Italy; France; Spain and Middle Eastern and African countries such as Israel, South Africa, Egypt, Sudan, Kuwait, Saudi Arabia, Qatar, and UAE
- APAC: The principal countries focused upon in this region are Japan, China, Australia, Singapore, South Korea, and India. APAC is one of the major markets that is untapped by the leading vendors

The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. In addition, it discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends that are emerging in the market.

Global Cancer Vaccines Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, EMEA, and APAC; it also covers the global cancer vaccines market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions
- Americas
- APAC
- EMEA

According to the report, cancer is a leading cause of deaths worldwide. According to the World Health Organization, 14-million incidences of cancer and 8.2-million cancer deaths were recorded in 2012. Lung, prostate, colorectal, cervical, and breast cancers remain the most common forms of cancer. Thus, there is a rise in demand for vaccines to prevent and treat cancers.

Key players in the global cancer vaccines market: Dendreon, GlaxoSmithKline and Merck

Other Prominent Vendors in the market are: Aduro BioTech, Advantagene, Advaxis, Agenus, AlphaVax, Altor BioScience, Amgen, Antigen Express, Argos Therapeutics, AVAX Technologies, Bavarian Nordic, Biothera, Bristol-Myers Squibb, Celldex Therapeutics, Cel-Sci, CureVac, Cytos, Galena Biopharma, Genexine, GlobeImmune, Gradalis, Heat Biologics, Immatics, ImmunoCellular Therapeutics, Immutep, Inovio Pharmaceuticals, Isa Pharmaceuticals, Juvaris Biotherapeutics, MedImmune, NewLink Genetics, Northwest Biotherapeutics, NovaRx, OncoThyreon, Oncovir, Oxford BioMedica, Prima BioMed, Progenics, Provectus Biopharmaceuticals, Sanofi, Sotio, Transgene, Ubivac, Vaccinogen, Vaxon Biotech and Vical

Market Driver
- Increased Prevalence of Cancers
- For a full, detailed list, view our report

Market Challenge
- Cold Chain Management
- For a full, detailed list, view our report

Market Trend
- Strategic Alliances
- For a full, detailed list, view our report

Key Questions Answered in this Report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?

Spanning over 64 pages, "Global Cancer Vaccines Market 2015-2019" report covers Executive Summary, List of Abbreviations, Scope of the Report, Market Research Methodology, Introduction, Market Landscape, Vaccine Approval Process, Market Landscape, Market Segmentation by Clinical Application of Vaccines, Global Prophylactic Vaccines Market, Global Therapeutic Vaccines Market, Geographical Segmentation, Buying Criteria, Key Brand Analysis, Pipeline Portfolio, Market Growth Drivers, Drivers and their Impact, Market Challenges, Impact of Drivers and Challenges, Market Trends, Trends and their Impact, Vendor Landscape, Opportunities for Cancer Vaccine Vendors, Key Vendor Analysis.

For further information on this report, please visit- http://www.marketresearchreports.com/technavio/global-cancer-vaccines-market-2015-2019

Find all Drug Delivery Reports at: http://www.marketresearchreports.com/drug-delivery

About Market Research Reports, Inc.
Market Research Reports, Inc. is the world's leading source for market research reports and market data. We provide you with the latest market research reports on global markets, key industries, leading companies, new products and latest industry analysis & trends.

For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter